Pertenant impormation. ILNS has a tremendous pipeline (including the Antisellin Platform) and is way ahead of many with there science. The value of the Antisellin Platform alone should put a nice valuation to ILNS.
Imagine prescribing a drug to a patient for 30 plus years and the associated income that comes with that.
Wow... this could be the blockbuster info we need....
If they can detect amyloid-beta build up years before AD on-set, that would be the marker to give Bapi or one of the future ILNS molecule therapies to patients well in advance; this is when they have shown the most promise! This could involve a VERY LARGE swath of the population that would be prescribed ILNS patented drug conjugates and therapies. Folks... this is BIG news IMO!!! Connect the dots.... !!!
News 
Market Data 
Discover 
